Appeals judges revived West Virginia claims over large opioid shipments.
A federal appeals court has reopened a major legal battle over how prescription painkillers were shipped into parts of West Virginia, putting three of the country’s biggest drug distributors back in the spotlight. The case, worth $2.5 billion, centers on the long-running opioid crisis in Cabell County and the city of Huntington. Both communities have struggled with deep poverty and some of the highest overdose death rates in the nation. Local officials argued for years that heavy shipments of powerful pain medicine helped push families into addiction, strained public services, and left long-lasting damage across the region.
A lower court had ruled in 2022 that McKesson, Cardinal Health, and AmerisourceBergen — now called Cencora — were not legally responsible for the widespread harm linked to the flow of prescription opioids. That judge decided the companies followed the rules in place at the time and that their role did not qualify as a public nuisance under state law. That win has now been set aside. A three-judge panel from the 4th Circuit Court of Appeals said the earlier decision misread West Virginia’s legal standards. The panel found that flooding a community with addictive medication can, in fact, meet the definition of a public nuisance if it creates dangerous conditions that affect the whole area.
The ruling is a major shift for Cabell County officials, who had argued that the companies sent far more pills than the region could possibly need. They said this pattern made it easier for painkillers to be misused or sold illegally. The appellate judges agreed that the effects of heavy distribution could create the kind of broad harm that public nuisance laws are meant to address. The panel noted that entire neighborhoods felt the fallout as overdose numbers climbed and local agencies were pushed to the brink.
Across the United States, prescription opioids have been linked to more than half a million deaths over the past twenty years. Families, towns, and states spent huge sums dealing with addiction, long-term disability, and emergency care tied to pain medicine. More than 4,000 lawsuits were filed by governments and other groups trying to recover costs. Those actions produced more than $50 billion in settlements and judgments. West Virginia was among the hardest hit, with Cabell County recording an overdose rate more than five times the national figure for the years included in the lawsuit.
While most states agreed to a nationwide settlement with the big distributors in 2021, West Virginia chose not to join. State leaders said the deal did not reflect the level of harm felt in their towns or the resources needed for treatment and recovery programs. They held firm that local governments still facing heavy overdose rates needed more direct help. The state recorded 770 overdose deaths in the twelve months ending in April of this year, a drop of 39% from the previous year but still a major strain on families and first responders.
The 4th Circuit’s move sends the West Virginia opioid case back to the trial court for further proceedings. The panel reversed the judge who had found that the companies did not fail in their duty to monitor suspicious orders or set proper controls that could limit the risk of drugs being diverted to illegal markets. With the ruling now voided, the local governments will have another chance to lay out evidence they believe shows a breakdown in oversight and a pattern of shipments far beyond medical need.
A spokesperson for Cencora said the company is disappointed with the decision and plans to review its options. The company noted that those options may include asking for further appellate review. McKesson and Cardinal Health have not yet issued public comments about the ruling. The next steps will determine whether the West Virginia opioid case proceeds to a new trial or moves into settlement talks, a process that could reshape how responsibility is assigned in one of the country’s most painful public health disasters.
Sources:
Opioid Distributors Must Face $2.5 Billion Suit After Ruling
US appeals court revives $2.5 billion opioid lawsuit in West Virginia
Join the conversation!